Ubrogepant and rimegepant: systematic review, meta-analysis, and meta-regression of clinical studies.

Guojun DongNaoko Adachi KjærgaardSaeed ShakibfarMaurizio Sessa

Published in: Expert opinion on drug safety (2023)

This study provided pooled incidence estimates of ubrogepant and rimegepant's ADRs and highlighted new safety aspects of the pharmacological treatment with ubrogepants and rimigepants from correlations obtained from the meta-regression.

Keyphrases

systematic review
meta analyses
risk factors
clinical trial
case control
smoking cessation